3138 results for «3176»
3138 results
The value of WATCHMAN therapy - Who should we treat?
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...
TAVI complex cases: intravascular hemolysis, Heyde syndrome & more
08 Feb 2025 – From PCR Tokyo Valves 2025
This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.
Mitral valve-in-valve and valve-in-ring electrosurgery
08 Feb 2025 – From PCR Tokyo Valves 2025
Future devices for structural heart interventions
08 Feb 2025 – From PCR Tokyo Valves 2025
Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.
Nightmare in TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...
M-TEER for secondary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.
Mitral complications
08 Feb 2025 – From PCR Tokyo Valves 2025
Advancing transcatheter solutions for tricuspid valve disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...
Optimizing diagnosis and treatment in multivalvular heart disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.
Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...
Advanced techniques for complex CTO interventions (Part 1) - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to develop treatment strategies in a patient with multiple CTOs, to learn how to approach technical difficulties in complex CTO PCI, and to learn about treatment options for typical complications of CTO PCI.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 Hotlines / Late-Breaking Trials: SWENTRY, Redo-TAVI, Early neo2, PORTICO NG, and Evolut Low Risk Trial
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TAVI:
- SWENTRY registry, Swedish Stroke Registry and National Patient Registry: late stroke after TAVI
- Redo-TAVI registry: implantation of a supplementary transcatheter aortic valve during TAVI
- Acurate neo2 TAVI valve results from the Early neo2 registry
- PORTICO NG: 30-day outcomes from a...
Revisiting T and TAP: key steps and pitfalls
18 May 2021 – From EuroPCR 2021
Watch this session if you want to learn the steps of T and TAP (T and Protrusion), to review the potential pitfalls of T and TAP (T and Protrusion) and to understand the limitations of angiography to accurately assess stent geometry at different steps of the...
Advanced techniques for complex CTO interventions (Part 2) - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to develop treatment strategies in a patient with multiple CTOs, to learn how to approach technical difficulties in complex CTO PCI, and to learn about treatment options for typical complications of CTO PCI.
This session was originally presented during EuroPCR 2021.
One-year results from the FUTURE-II trial
19 May 2021 – From EuroPCR 2021
This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.
Advances in investigational mitral and tricuspid therapies
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard, Vinayak Bapat, Thomas Modine, Firas Zahr and Azeem Latib in order to see a review of the Medtronic TMVR/TTVR EFS studies and system, to review one mitral EFS case and one tricuspid EFS case, and to discuss future of TMVR/TTVR in...
Meta-analysis of elective coronary revascularization vs medical therapy alone
18 May 2021 – From EuroPCR 2021
This session, originally broadcast during EuroPCR 2021, presents a meta-analysis based on 25 trials dealing with revascularization in patients with chronic coronary syndromes and enables our experts to discuss the strengths and weaknesses of this study.
Complete 2-year follow-up from the Evolut low risk trial
18 May 2021 – From EuroPCR 2021
This session was originally presented during EuroPCR 2021.
Planning for a long run: life-time management of bioprosthetic valve implantation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan Windecker, Anna Sonia Petronio, Mohamed Abdel-Wahab, Lars Sondergaard and Hendrik Treede in order to learn about life-time management strategies of aortic stenosis patients, to discuss evolving multifactorial aspects that influence the choice of aortic stenosis patient treatment, and to explore THV...
Presentation of the PCR Tricuspid Focus Group
19 May 2021 – From EuroPCR 2021
This session was originally presented during EuroPCR 2021.
